MMP9 and pulmonary arterial hypertension: Proteolytic enzymes are also implicated in the migration, proliferation and resistance to apoptosis of PASMCs [38,39] and represent another potential therapeutic target as PASMCs exhibit increased gelatinase activity in PAH [40,41] and statins such as simvastatin attenuated MMP-9 production in cultured cells.